# Minimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid Leukemia

> **NCT04679285** · — · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 9 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04679285
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-26
- **Primary completion:** 2022-09-04
- **Final completion:** 2022-09-04
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04679285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04679285, "Minimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04679285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*